Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-16 4:30 pm Purchase |
2025-04-14 | 13G | Can-Fite BioPharma Ltd. CANF |
Orca Capital AG | 375,000,000 9.700% |
375,000,000![]() (New Position) |
Filing History |
2025-04-14 4:30 pm Sale |
2025-04-11 | 13G | Venus Concept Inc. VERO |
Orca Capital AG | 0 0.000% |
-83,429![]() (Position Closed) |
Filing History |
2025-04-11 4:30 pm Purchase |
2025-04-09 | 13G | Venus Concept Inc. VERO |
Orca Capital AG | 83,429 8.000% |
83,429![]() (New Position) |
Filing History |
2025-03-17 5:53 pm Sale |
2025-03-14 | 13G | Dogwood Therapeutics, Inc. DWTX |
Orca Capital AG | 69,821 3.700% |
-45,969![]() (-39.70%) |
Filing History |
2025-03-17 5:49 pm Purchase |
2025-03-12 | 13G | Dogwood Therapeutics, Inc. DWTX |
Orca Capital AG | 115,790 6.100% |
115,790![]() (New Position) |
Filing History |
2025-02-18 4:15 pm Sale |
2025-02-14 | 13G | Lixte Biotechnology Holdings, Inc. LIXT |
Orca Capital AG | 120,012 4.500% |
-97,380![]() (-44.79%) |
Filing History |
2025-02-13 4:48 pm Purchase |
2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT |
Orca Capital AG | 217,392 8.100% |
217,392![]() (New Position) |
Filing History |
2025-02-04 7:51 pm Sale |
2025-01-31 | 13G | Enveric Biosciences, Inc. ENVB |
Orca Capital AG | 97,019 4.900% |
-69,648![]() (-41.79%) |
Filing History |
2025-02-04 7:47 pm Purchase |
2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB |
Orca Capital AG | 166,667 8.700% |
166,667![]() (New Position) |
Filing History |
2025-02-04 7:42 pm Sale |
2025-01-31 | 13G | SuperCom Ltd. SPCB |
Orca Capital AG | 124,583 3.600% |
-148,144![]() (-54.32%) |
Filing History |
2025-02-03 5:21 pm Sale |
2025-01-31 | 13G | Singularity Future Technology Ltd. SGLY |
Orca Capital AG | 0 0.000% |
-233,334![]() (Position Closed) |
Filing History |
2025-01-31 2:12 pm Purchase |
2025-01-30 | 13G | SuperCom Ltd. SPCB |
Orca Capital AG | 272,727 7.800% |
272,727![]() (New Position) |
Filing History |
2025-01-28 5:03 pm Purchase |
2025-01-24 | 13G | Singularity Future Technology Ltd. SGLY |
Orca Capital AG | 233,334 5.600% |
233,334![]() (New Position) |
Filing History |
2025-01-23 3:45 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
Orca Capital AG | 514,965 9.900% |
514,965![]() (New Position) |
Filing History |
2025-01-21 06:16 am Sale |
2025-01-13 | 13G | Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT |
Orca Capital AG | 0 0.000% |
-92,000![]() (Position Closed) |
Filing History |
2025-01-16 11:56 am Purchase |
2025-01-05 | 13G | Fujian Blue Hat Interactive Entertainment Technology Ltd. BHAT |
Orca Capital AG | 92,000 8.100% |
92,000![]() (New Position) |
Filing History |